PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
for
Glioma, Medulloblastoma, Ependymoma, Glioblastoma
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06161519
Phase1, Phase2, Recruiting
18F-Fluciclovine PET-MRI in High-grade Glioma
for
Glioma, High Grade Glioma, Glioma, Malignant,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 1 - 21
Code: NCT05553041
Early_phase1, Recruiting
OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
for
Recurrent Glioblastoma
Location: Gainesville FL
Sponsor: University of Florida
Sex: All
Age: 18 - 70+
Code: NCT06558214
Phase2, Recruiting
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
for
High Grade Glioma, Meningioma, Embryonal Tumor, Medulloblastoma,
Location: Columbus OH, Cincinnati OH
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 4 - 39
Code: NCT05278208
Phase1, Phase2, Recruiting
Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
for
Glioblastoma
Location: Louisville KY
Sponsor: University of Louisville
Sex: All
Age: 18+
Code: NCT05700955
Phase1, Recruiting
Interested in new glioblastoma multiforme trials?
Get alerts for new trials in your area by subscribing now
Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
for
Glioblastoma
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma